StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Estimated future intangible amortization by Year

Estimated future intangible amortization — Year 5 ($M) ($M)

Pfizer Estimated future intangible amortization: $2,732M in FY2025, down 3.4% from a year earlier.

Latest, FY2025
2,732
Period ended Dec 31, 2025
Change on a year earlier
-3.4%
2,829 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-Q / 10-K Goodwill & Other Intangible Assets Footnote.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstimated future intangible amortization — Year 5 ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,732-3.4%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 20242,829-23.6%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 20233,702+5.7%Form 10-K (filed 2024-02-22) ↗
FY2022Dec 31, 20223,503+43.0%Form 10-K (filed 2023-02-23) ↗
FY2021Dec 31, 20212,449-1.7%Form 10-K (filed 2022-02-24) ↗
FY2020Dec 31, 20202,492-4.2%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 20192,602-10.9%Form 10-K (filed 2020-02-27) ↗
FY2018Dec 31, 20182,920-9.4%Form 10-K (filed 2019-02-28) ↗
FY2017Dec 31, 20173,223-3.7%Form 10-K (filed 2018-02-22) ↗
FY2016Dec 31, 20163,348+38.4%Form 10-K (filed 2017-02-23) ↗
FY2015Dec 31, 20152,419–Form 10-K (filed 2016-02-29) ↗

Cite this data

StockData. (2026). Pfizer Estimated future intangible amortization ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/intang-est-y5

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.